Avenir Corporation’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-302,852
| Closed | -$1.24M | – | 69 |
|
|
2022
Q1 | $1.24M | Buy |
302,852
+1,000
| +0.3% | +$3.63K | 0.1% | 38 |
|
|
2021
Q4 | $1.08M | Buy |
301,852
+555
| +0.2% | +$1.94K | 0.08% | 40 |
|
|
2021
Q3 | $1.1M | Hold |
301,297
| – | – | 0.09% | 43 |
|
|
2021
Q2 | $1.31M | Hold |
301,297
| – | – | 0.1% | 41 |
|
|
2021
Q1 | $1.24M | Hold |
301,297
| – | – | 0.11% | 43 |
|
|
2020
Q4 | $1.2M | Buy |
301,297
+17,500
| +6% | +$56.6K | 0.11% | 40 |
|
|
2020
Q3 | $766K | Hold |
283,797
| – | – | 0.08% | 46 |
|
|
2020
Q2 | $780K | Hold |
283,797
| – | – | 0.09% | 44 |
|
|
2020
Q1 | $670K | Buy |
283,797
+700
| +0.2% | +$2.38K | 0.09% | 45 |
|
|
2019
Q4 | $1.33M | Sell |
283,097
-3,000
| -1% | -$12.3K | 0.14% | 45 |
|
|
2019
Q3 | $957K | Hold |
286,097
| – | – | 0.1% | 49 |
|
|
2019
Q2 | $941K | Sell |
286,097
-2,500
| -0.9% | -$7.23K | 0.1% | 50 |
|
|
2019
Q1 | $874K | Sell |
288,597
-1,500
| -0.5% | -$4.86K | 0.09% | 50 |
|
|
2018
Q4 | $789K | Sell |
290,097
-1,500
| -0.5% | -$4.94K | 0.1% | 49 |
|
|
2018
Q3 | $980K | Hold |
291,597
| – | – | 0.11% | 51 |
|
|
2018
Q2 | $752K | Hold |
291,597
| – | – | 0.09% | 51 |
|
|
2018
Q1 | $642K | Hold |
291,597
| – | – | 0.07% | 55 |
|
|
2017
Q4 | $580K | Sell |
291,597
-60,088
| -17% | -$131K | 0.05% | 59 |
|
|
2017
Q3 | $1.14M | Hold |
351,685
| – | – | 0.1% | 48 |
|
|
2017
Q2 | $1.13M | Buy |
351,685
+30,150
| +9% | +$85.5K | 0.1% | 50 |
|
|
2017
Q1 | $913K | Hold |
321,535
| – | – | 0.08% | 51 |
|
|
2016
Q4 | $749K | Hold |
321,535
| – | – | 0.07% | 51 |
|
|
2016
Q3 | $540K | Hold |
321,535
| – | – | 0.05% | 52 |
|
|
2016
Q2 | $338K | Hold |
321,535
| – | – | 0.03% | 60 |
|
|
2016
Q1 | $280K | Hold |
321,535
| – | – | 0.02% | 60 |
|
|
2015
Q4 | $389K | Hold |
321,535
| – | – | 0.03% | 57 |
|
|
2015
Q3 | $547K | Hold |
321,535
| – | – | 0.05% | 48 |
|
|
2015
Q2 | $669K | Sell |
321,535
-2,000
| -0.6% | -$4.85K | 0.05% | 43 |
|
|
2015
Q1 | $877K | Buy |
323,535
+10,000
| +3% | +$25.4K | 0.06% | 41 |
|
|
2014
Q4 | $806K | Sell |
313,535
-25,000
| -7% | -$56.2K | 0.06% | 45 |
|
|
2014
Q3 | $620K | Sell |
338,535
-2,500
| -0.7% | -$5.45K | 0.05% | 50 |
|
|
2014
Q2 | $911K | Buy |
341,035
+2,300
| +0.7% | +$6.92K | 0.08% | 48 |
|
|
2014
Q1 | $1.19M | Buy |
338,735
+1,650
| +0.5% | +$7.32K | 0.1% | 40 |
|
|
2013
Q4 | $1.51M | Buy |
337,085
+59,625
| +21% | +$243K | 0.14% | 39 |
|
|
2013
Q3 | $1.13M | Hold |
277,460
| – | – | 0.11% | 43 |
|
|
2013
Q2 | $1.15M | Buy |
+277,460
| New | +$1.07M | 0.12% | 44 |
|
Other funds holding ATRS
Avenir Corporation's ATRS Position: Q2 2022 in Review
Avenir Corporation sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 302,852 shares — an estimated $1.24M sold.
Avenir Corporation first reported a position in ATRS in Q2 2013 and held it in 36 quarters. The position peaked at $1.51M in Q4 2013. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Avenir Corporation reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Avenir Corporation sold 302,852 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.24M.
- Avenir Corporation first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 36 quarters.
- Avenir Corporation's Antares Pharma, Inc. position peaked at $1.51M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Avenir Corporation's 13F filing for Q2 2022, filed 11 Aug 2022.